| NCT06150742 | Nafamostat Efficacy in Phase 3 Registrational CRRT Study | RECRUITING | NA | 2024-08-15 | 2025-12 | 2025-12 |
| NCT02662764 | Study to Evaluate the Overall Performance of the Zalviso Systemâ„¢ (Sufentanil Sublingual Tablet System) 15 mcg | COMPLETED | PHASE3 | 2016-09-28 | 2017-05-05 | 2017-04-14 |
| NCT02662556 | A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain | COMPLETED | PHASE3 | 2016-03 | 2016-07 | 2016-06 |
| NCT02447848 | Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain | COMPLETED | PHASE3 | 2015-10 | 2016-07 | 2016-06 |
| NCT02356588 | A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery | COMPLETED | PHASE3 | 2015-02 | 2015-08 | 2015-06 |
| NCT02082236 | Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects | COMPLETED | PHASE1 | 2014-05 | 2014-05 | 2014-05 |
| NCT01761565 | Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab | COMPLETED | PHASE1 | 2013-01 | 2013-02 | 2013-02 |
| NCT01721070 | Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics | COMPLETED | PHASE1 | 2012-11 | 2012-12 | 2012-12 |
| NCT01710345 | Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy | COMPLETED | PHASE2 | 2012-10 | 2013-02 | 2013-02 |
| NCT01660763 | Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery | COMPLETED | PHASE3 | 2012-08 | 2013-05 | 2013-04 |
| NCT01639729 | Effect of Delivery Route on PK of Sufentanil NanoTab | COMPLETED | PHASE1 | 2012-07 | 2012-07 | 2012-07 |
| NCT01539538 | A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalvisoâ„¢)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain | COMPLETED | PHASE3 | 2012-04 | 2012-12 | 2012-12 |
| NCT01539642 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalvisoâ„¢) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery | COMPLETED | PHASE3 | 2012-02 | 2013-02 | 2013-01 |
| NCT00894699 | A Study to Evaluate the Clinical Efficacy, Safety and Tolerability of ARX-F03 Sublingual Sufentanil/Triazolam NanoTabâ„¢ in Patients Undergoing an Elective Abdominal Liposuction Procedure | COMPLETED | PHASE2 | 2009-06 | 2009-09 | 2009-09 |
| NCT00833040 | A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain | COMPLETED | PHASE2 | 2009-04 | 2010-03 | 2010-03 |
| NCT00859313 | An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement | COMPLETED | PHASE2 | 2009-04 | 2009-08 | 2009-08 |
| NCT00718081 | A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery | COMPLETED | PHASE2 | 2008-08 | 2009-03 | 2009-03 |
| NCT00612534 | A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement | COMPLETED | PHASE2 | 2008-03 | 2008-10 | 2008-10 |